Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-11-05

Clinical Trial Update: IPF Drug Deposition Study [Phase 1]

View source ↗

Summary

Phase 1 deposition study for an idiopathic pulmonary fibrosis drug has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Royal Brompton & Harefield NHS Foundation Trust | Conditions: Idiopathic Pulmonary Fibrosis | Phase 1 | Status: COMPLETED